03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
It appears that we are in “hurry up and wait” mode. We know that COVID-19 (i.e., the 2019 Novel Co...
Read More >
On December 4, 2019, Judge Ellen L. Hollander of the United States District Court for the District o...
Read More >
As of April 13, 2020, Pennsylvania has over 24,000 confirmed COVID-19 cases. With a wide variety of ...
Read More >
The Internal Revenue Service (“IRS”) recently proposed Regulation 122180-18 (the “Proposed Regula...
Read More >
After recently finishing off the public comment period for one National Pollutant Discharge Eliminat...
Read More >
OSHA’s General Duty Clause requires an employer to provide a workplace free from recognized hazards...
Read More >